An investigation for investors in EXACT Sciences Corporation (NASDAQ:EXAS) shares over potential securities laws violations by EXACT Sciences was announced and NASDAQ:EXAS stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 10/28/2015 -- An investigation for shareholders of EXACT Sciences Corporation (NASDAQ:EXAS) shares over potential securities laws violations by EXACT Sciences and certain of its directors and officers in connection certain financial statements was announced.
Investors who purchased shares of EXACT Sciences Corporation (NASDAQ:EXAS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation or call +1(858) 779 - 1554.
The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of EXACT Sciences Corporation (NASDAQ:EXAS) concerning whether a series of statements by EXACT Sciences regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
The U.S. Preventive Services Task Force ("USPSTF") issued a recommendation statements for colorectal cancer screening. The USPSTF included Cologuard in the draft guidelines as an alternative screening test, along with CT colonography. The draft guidelines recommend an "A" rating for colorectal cancer screening starting at age 50 and continuing until age 75. Screening for individuals age 75 through 85 is graded a "C." and The USPSTF recommended an "D" rating against screening for colorectal cancer in adults older than age 85 years.
On October 5, 2015, EXACT Sciences Corporation issued a statement following the U.S. USPSTF recommendation statement for colorectal cancer screening. Among other things, EXACT Sciences Corporation said that this approach represents a change from the 2008 recommendations, which assigned specific grades for different tests, including an "I" rating for stool-based DNA.
Shares of EXACT Sciences Corporation (NASDAQ:EXAS) declined to as low as $6.79 per share on October 15, 2015.
On October 27, 2015, shares of EXACT Sciences Corporation closed at $8.11 per share.
Those who purchased NASDAQ:EXAS shares have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego